HIGHLIGHTS
- who: Zhou Yang from the Human umbilical vein endothelial cells (HUVECs) were purchased from Allcells, Inc(Alameda, CA, USA) and cultured in Endothelial Cell Medium (ECM have published the Article: A new risk factor indicator for papillary thyroid cancer based on immune infiltration, in the Journal: (JOURNAL)
- what: The research demonstrated a comprehensive panorama of immune infiltration in thyroid cancer which may provide potential value for immunotherapy. The research investigated 22 types of immune cells, various immune checkpoints, stromal cells including CAFs and endothelial cells (ECs), and TLSs in thyroid cancer based on data from . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.